The scientific consensus on vaping has shifted dramatically. What was once considered merely "not proven safe" has now crossed into "likely causes cancer" territory, based on a comprehensive new review of the evidence.
The findings are stark: vape aerosols contain chemicals that demonstrate almost all ten of the key characteristics of carcinogens recognized by the World Health Organization. Researchers have found DNA mutations in the mouth and lung tissues of people who vape, along with alterations to cancer biomarkers—the cellular changes that precede tumor development.
This isn't just correlation anymore. The review, published in The Conversation, identifies a mechanistic pathway: carcinogenic metals from heating elements are being absorbed into vapers' bodies, and nicotine itself appears to play a role in DNA damage.
The shift in scientific opinion has been rapid. Between 2017 and 2019, researchers generally stated that insufficient evidence existed to draw conclusions. By 2024-2025, many scientists were expressing serious concern, with several noting that the claim "vaping has a lower cancer risk than smoking" could no longer be supported by the evidence.
Now, before the "I told you so" crowd gets too excited: we still don't have direct proof of increased cancer cases among vapers. That will require decades of long-term studies—similar to how establishing tobacco's cancer link took nearly 100 years. The lag time between exposure and cancer diagnosis is frustratingly long for public health officials trying to prevent harm now.
But here's the thing about waiting for absolute certainty: by the time you have it, millions of people have already been exposed. The precautionary principle exists for a reason.
This matters especially for young people. The United States has seen explosive growth in youth vaping rates over the past decade, with flavored products making nicotine addiction palatable to a new generation. The lung tissues developing in teenagers don't benefit from our need for multi-decade longitudinal studies.
The science here is doing what science does best: accumulating evidence, identifying mechanisms, and revising conclusions when the data demands it. The early promise that vaping might be a harm-reduction tool for smokers trying to quit has collided with the reality that it created its own public health crisis—one that disproportionately affects people who never smoked in the first place.




